Everhart Financial Group’s Gilead Sciences GILD Stock Holding History

Everhart Financial Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.55M	Buy	10,418 +772	+8%	+$108K	0.1%	106
2026 Q2	$1.22M	Sell	9,646 -1,593	-14%	-$210K	0.08%	139
2026 Q1	$1.57M	Buy	11,239 +2,464	+28%	+$345K	0.13%	102
2025 Q4	$1.08M	Buy	8,775 +1,425	+19%	+$173K	0.1%	142
2025 Q3	$816K	Buy	7,350 +2,165	+42%	+$246K	0.08%	179
2025 Q2	$575K	Buy	5,185 +1,143	+28%	+$122K	0.07%	210
2025 Q1	$453K	Buy	4,042 +1,450	+56%	+$150K	0.06%	224
2024 Q4	$239K	Buy	+2,592	New	+$233K	0.05%	283

Other funds holding GILD

CIM

Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return

MSV

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

CapWealth Advisors Franklin, Tennessee $1.32B AUM 21.6% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

FFBTD

First Financial Bank - Trust Division Hamilton, Ohio $1.39B AUM 15.59% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

VWM

Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return

SCA

Stokes Capital Advisors Greenwood, South Carolina $455M AUM 9.69% 1-Year Est. Return

Everhart Financial Group's GILD Position: Q3 2026 in Review

Everhart Financial Group increased its Gilead Sciences (GILD) stake by 8% in Q3 2026, buying an estimated $108K and bringing the position to 10,418 shares worth $1.55M. The position accounts for 0.1% of the portfolio, ranked #106.

Everhart Financial Group first reported a position in GILD in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.57M in Q1 2026. 119 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

Everhart Financial Group held 10,418 shares of Gilead Sciences worth $1.55M as of Q3 2026.
Everhart Financial Group bought 772 Gilead Sciences shares in Q3 2026, an estimated $108K.
Gilead Sciences made up 0.1% of Everhart Financial Group's portfolio in Q3 2026, its #106 holding.
Everhart Financial Group first reported a position in Gilead Sciences in Q4 2024 and has held it in 8 quarters since.
Everhart Financial Group's Gilead Sciences position peaked at $1.57M in Q1 2026.
119 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Everhart Financial Group's 13F filing for Q3 2026, filed 8 Oct 2026.